These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Streptococcal pharyngitis. Evaluation of erythromycin, erythromycin-sulfas, and sulfamethoxazole (possible antagonism between erythromycin and sulfas). Hughes WT; Collier RN Am J Dis Child; 1969 Nov; 118(5):700-7. PubMed ID: 5348368 [No Abstract] [Full Text] [Related]
3. Erythromycin levels in serum during treatment with erythromycin stearate and base. Saarni H; Kanto J; Allonen H Ann Clin Res; 1979 Oct; 11(5):196-8. PubMed ID: 397800 [TBL] [Abstract][Full Text] [Related]
4. N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man. Majer J; Stanaszek RS; Mueller SL; Marti G Drug Metab Dispos; 1978; 6(6):673-6. PubMed ID: 33030 [TBL] [Abstract][Full Text] [Related]
5. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate. Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656 [No Abstract] [Full Text] [Related]
6. Warfarin interaction with erythromycin. Sato RI; Gray DR; Brown SE Arch Intern Med; 1984 Dec; 144(12):2413-4. PubMed ID: 6508448 [TBL] [Abstract][Full Text] [Related]
7. Quantitative determination of erythromycin 2'-ethylsuccinate in human plasma by fast atom bombardment mass spectrometry. Ottoila P; Taskinen J Biomed Environ Mass Spectrom; 1987 Nov; 14(11):659-62. PubMed ID: 2962674 [TBL] [Abstract][Full Text] [Related]
11. Erythromycin assay: specificity of determining erythromycin A in relation to erythromycin B. Chatterjee NR; Badve VM Hindustan Antibiot Bull; 1983; 25(3-4):131-4. PubMed ID: 6674276 [No Abstract] [Full Text] [Related]
12. Ototoxicity of erythromycin in man: electrophysiologic approach. Sacristán JA; Angeles De Cos M; Soto J; Zurbano F; Pascual J; Tasis A; Valle R; De Pablos C Am J Otol; 1993 Mar; 14(2):186-8. PubMed ID: 8503495 [TBL] [Abstract][Full Text] [Related]
13. [Comparative studies of cyclic 11, 12 erythromycin carbonate (davercin) and erythromycin a levels in lung tissue, serum and bronchial secretions]. Krakówka P; Kazimierczak A; Kuś J; Zagdańska J; Schaeffer A; Bireta K; Zdziarska H; Olechnowicz H; Sawicka E; Kołb P Pneumonol Pol; 1989 Jan; 57(1):25-8. PubMed ID: 2813147 [TBL] [Abstract][Full Text] [Related]
15. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food. Clayton D; Leslie A J Int Med Res; 1981; 9(6):470-7. PubMed ID: 7319133 [TBL] [Abstract][Full Text] [Related]
16. Selection of an oral erythromycin product. Fraser DG Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290 [TBL] [Abstract][Full Text] [Related]
17. Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris. Al-Mishari MA Clin Ther; 1987; 9(3):273-80. PubMed ID: 2955899 [TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic drug interaction between erythromycin and triazolam. Phillips JP; Antal EJ; Smith RB J Clin Psychopharmacol; 1986 Oct; 6(5):297-9. PubMed ID: 3771812 [TBL] [Abstract][Full Text] [Related]
19. Erythromycin resistance in Danish Staphylococcus aureus hospital strains with emphasis on erythromycin consumption. Westh H; Rosdahl VT; Friis H APMIS; 1989 Dec; 97(12):1121-4. PubMed ID: 2611026 [TBL] [Abstract][Full Text] [Related]
20. [QT prolongation and circulatory arrest after an injection of erythromycin in a newborn infant]. Benoit A; Bodiou C; Villain E; Bavoux F; Checoury A; Badoual J Arch Fr Pediatr; 1991 Jan; 48(1):39-41. PubMed ID: 2018421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]